Shell's $720m Cyprus Dispute Casts a Shadow Over a Quarter of Record Cash Generation

Shell's Q2 earnings surge to $9.84bn, beating forecasts, but a $720m Aphrodite stake sale to MOL faces Cyprus regulatory backlash.

The second quarter of 2026 delivered Shell its strongest earnings beat in recent memory, yet the company now finds itself juggling a regulatory spat in the Eastern Mediterranean alongside the operational momentum that drove those numbers. The juxtaposition — a disputed asset sale on one front, a green-lit Australian expansion on another — captures the twin pressures facing Europe's largest oil major as it tries to slim down and double down simultaneously.

The Numbers That Quieted the Skeptics

Shell's adjusted earnings for the April-to-June period came in at $9.84bn, more than double the $4.26bn reported a year earlier and comfortably ahead of the $8.79bn consensus forecast. The primary engine was crude: Brent averaged $104 a barrel during the quarter, a sharp jump from the $81 average recorded in the first three months of the year. Revenue of $94.66bn also beat expectations, landing roughly 9 percent above analyst projections.

Beneath the headline figures, however, lay a notable anomaly. Earnings per share of $1.76 undershot the consensus estimate of $2.80 by a substantial 37 percent — a discrepancy that analysts attributed to the mechanics of the company's ongoing share buyback programme and the accounting treatment of its recent ARC Resources acquisition. Cash generation told a healthier story: free cash flow reached $17.5bn, supported by an operating cash flow of $21.4bn and a working-capital inflow of $3.4bn. Net debt fell from $52.6bn in the first quarter to $41.8bn, underscoring the balance-sheet repair under way.

A $4.2bn Buyback and a Dividend That Keeps Flowing

The strong quarter provided the backdrop for an aggressive capital-return programme. Shell launched a $4.232bn share repurchase scheme on 30 July, comprising $3bn in fresh authorisation plus $1.232bn in "catch-up" buybacks that had been paused during the ARC Resources deal. The programme is slated to run until the release of third-quarter results, with all repurchased shares cancelled.

The buyback machine has been running at pace. On 6 August, Shell acquired 1.625 million shares for cancellation across the LSE, Chi-X and XAMS venues; the previous day it had bought 1.075 million shares at a volume-weighted average price of 32.96 pence on the London exchange and €38.75 on XAMS. Following the cancellations, the company's voting-rights count stood at 7,845,622,110 as of 31 July.

Shareholders also have a dividend to look forward to. The board declared an interim payout of $0.3906 per ordinary share — equivalent to $0.7812 per ADS — with the ex-dividend date set for 13 August for ordinary shares and 14 August for ADSs. Payment lands on 21 September.

The Aphrodite Question

The most immediate source of friction sits off the coast of Cyprus. Nicosia has accused Shell of proceeding with the sale of its 35 percent stake in the Aphrodite gas field to Hungary's MOL without securing the requisite government approval. The $720m transaction was announced in late July, but the dispute over the missing authorisation erupted publicly this week. The legal and temporal outlook for the deal remains unresolved.

The timing is awkward for a company that prides itself on disciplined execution. On the same day the Cypriot government aired its grievances, Shell announced a final investment decision for Phase 3 of the Surat coal-seam gas project in Australia — a roughly A$713m commitment expected to reach peak production of 79 million cubic feet per day from 2028. One deal stalled by regulatory pushback, another advancing without impediment: the contrast could hardly be starker.

Shedding Renewables, Sharpening Focus

Beyond the quarterly numbers, Shell continues to reshape its portfolio. The company has agreed to sell its entire European onshore renewables business to TotalEnergies, a transaction covering 500 megawatts of solar and wind capacity already operational or under construction — predominantly in Italy and the Netherlands — plus a 3.5-gigawatt project pipeline spanning solar, wind and battery storage across Italy, the UK and Spain. The purchase price was not disclosed, and completion is expected by the end of 2026, subject to regulatory clearances. The divestment aligns with Shell's stated strategy of concentrating capital on higher-return core operations.

There has been movement in the boardroom as well. Holly Keller Koeppel assumed the chairmanship of the audit and risk committee on 1 August, succeeding Ann Godbehere, who departed the board the same day. Meanwhile, CFO Sinead Gorman sold 30,000 ordinary shares in late July at an average price of 3,369 pence, realising approximately £1.01m.

What the Street Is Saying

The earnings beat has kept sell-side sentiment firmly positive. Jefferies reaffirmed its "Buy" rating with a price target of 4,500 pence in late July, and Berenberg followed suit in early August with a "Buy" recommendation and a 4,000 pence target. Both houses cited the second-quarter profit surge as the key driver of their conviction.

The share price itself has been something of a mixed bag in the short term. The stock closed Friday at €38.31, down 1.33 percent on the day, though it remains 6.31 percent higher over the past month and up 22.42 percent since the start of the year. That leaves the shares about 7.28 percent below the 52-week high of €41.32 touched in late March. With capital expenditure guidance for 2026 held at $24bn to $26bn — including the ARC Resources acquisition — and $20bn to $22bn pencilled in for each of 2027 and 2028, the investment story remains one of restraint paired with generous returns. Whether the Aphrodite dispute adds a wrinkle to that narrative is a question the coming weeks will answer.